3[3]JANKOVIC J,SCHWARTZ K S.Clinical correlates of response to botulinum toxin injections[J].Arch Neurol,1991,48(12):1253-1256.
4[4]BERWECK S,SCHROEDER A S,LEE S H,et al.Secondary non-response due to antibody formationin a child after three injection of botulinum toxin B into the salivary glands[J].Dev Med Child Neurol,2007,49(1):62-64.
5[5]BOLES J,WEST M,MONTGOMERY V,et al.Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB HC) immune response and protection in the rhesus monkey[J].Toxicon,2006,47(8):877-884.
6[6]DOLIMBEK B Z,AOKI K R,STEWARD L E,et al.Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A[J].Mol Immunol,2007,44(5):1029-1041.
二级参考文献1
1D. Dressler,J. C. Rothwell,C. D. Marsden. Comparing biological potencies of Botox and Dysport with a mouse diaphragm model may mislead[J] 1998,Journal of Neurology(6-7):332
8Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use. in facial aesthetic surgery[J].Plastc Reconstr Surg, 1999,103 : 701-703.
